HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...
Hlavní autoři: | Goulbourne, C, Vaux, D |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Portland Press
2010
|
Podobné jednotky
-
The structural basis of ZMPSTE24-dependent laminopathies
Autor: Quigley, A, a další
Vydáno: (2013) -
The structural basis of ZMPSTE24-dependent laminopathies.
Autor: Quigley, A, a další
Vydáno: (2013) -
Prelamin A and ZMPSTE24 in premature and physiological aging
Autor: Howard J. Worman, a další
Vydáno: (2023-12-01) -
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
Autor: Moritz Messner, a další
Vydáno: (2020-08-01) -
Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
Autor: Jemima Barrowman, a další
Vydáno: (2012-01-01)